Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma.

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

1989 • 1,003 citations

Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen

1992 • 241 citations

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

1989 • 240 citations

Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.

1984 • 234 citations

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

1990 • 206 citations

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.

1991 • 200 citations

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.

1993 • 181 citations

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

1989 • 179 citations

Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

1988 • 153 citations

Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma.

1993 • 147 citations

Current therapy for malignant melanoma.

1989 • 127 citations

A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.

1992 • 114 citations

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

1989 • 114 citations

Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study.

1991 • 93 citations

Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells.

1990 • 82 citations

Studies of interferons in the therapy of melanoma.

1991 • 67 citations

Effective chemotherapy for melanoma after treatment with interleukin-2

1992 • 57 citations

Interferon α-2a and Dacarbazine in Melanoma

1990 • 48 citations

Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma.

1993 • 48 citations

Sequential chemoimmunotherapy for metastatic melanoma.

1991 • 42 citations

In Vitro and In Vivo Effects of Cisplatin on the Generation of Lymphokine-Activated Killer Cells

1990 • 22 citations

Chemotherapy drug interactions with biological agents.

1993 • 11 citations